Evaluation of periodontal inflamed surface area, serum Interleukin-12, Interleukin-18 levels in Stage III periodontitis patients with and without Type 2 Diabetes Mellitus- A Cross Sectional Study

none0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年6月26日

试验速览

暂无简介。

•Group I Periodontally healthy patients GI is equal to0 probing depth PPD less than or equal to 3 mm CAL is equal to 0 with no radiographic evidence of bone loss
•Group II Stage III periodontitis with GI greater than 1 PPD more than or equal to 6mm and CAL more than or equal to 5mm
•Group III Stage III periodontitis with T2DM patients GI more than 1 PPD more than or equal to 6mm and CAL more than or equal to 5mm HbA1c levels between 5 to 7 percent

•Patients who have undergone any periodontal therapy in the past 6 months
•Patients with symptoms of acute illness
•Patients who are on immunosuppressive therapy
•Systemic anti inflammatory treatment within the previous 3 months or regular use of specific drugs known to affect periodontal tissues
•Pregnant women and lactating mothers

发起方

none